Scientific Program

8:30 – 9:00
rare bleeding d/o then & now

Prof. Flora Peyvandi 🇮🇹

rare bleeding d/o then & now

Session 1: Bleeding Disorders

9:00 – 9:20
Novel Therapies in Hemophilia

Prof. Yasser Wali 🇴🇲

Novel Therapies in Hemophilia

9:20 – 9:40
Von Willebrand Disease: Diagnosis and Management Updates

Prof. Flora Peyvandi 🇮🇹

Von Willebrand Disease: Diagnosis and Management Updates

9:40 – 10:00
Liver Disease–Associated Coagulopathy: Rethinking "Bleeding Risk"

Dr. Ashraf Warsi 🇸🇦

Liver Disease–Associated Coagulopathy: Rethinking "Bleeding Risk"

10:00 – 10:20
Acquired Hemophilia A: Diagnosis and Emergency Management

Prof. Tarek Owaida 🇸🇦

Acquired Hemophilia A: Diagnosis and Emergency Management

10:20 – 10:30

Q&A

10:30 – 11:00

Break

Session 2: Thrombosis (Adults/Peds)

11:00 – 11:20
Pediatric Thrombosis: ASH-ISTH 2025 Guidelines

Hadeel Mohammad 🇰🇼

Pediatric Thrombosis: ASH-ISTH 2025 Guidelines

11:20 – 11:40
Anticoagulation in Special Populations: Obesity, Renal Disease, and the Elderly

Prof. Farjah AlQahtani 🇸🇦

Anticoagulation in Special Populations: Obesity, Renal Disease, and the Elderly

11:40 – 12:00
Managing Thrombosis in Cancer Patients: A Shifting Paradigm

Dr. Eman Mansory 🇸🇦

Managing Thrombosis in Cancer Patients: A Shifting Paradigm

12:00 – 12:10
When to Screen for Thrombophilia: Adult Perspectives

Dr. Ashraf Warsi 🇸🇦

When to Screen for Thrombophilia: Adult Perspectives

12:10 – 12:20
When to Screen for Thrombophilia: Pediatric Perspectives

Prof. Tamer Hassan 🇪🇬

When to Screen for Thrombophilia: Pediatric Perspectives

12:20 – 12:30

Q&A

12:30 – 13:30

Lunch

13:30 – 14:20

Satellite Symposium: Roche

02:20 – 02:40
Iron Deficiency in Women: Beyond Pregnancy and Menorrhagia

Tahera Zafar

Iron Deficiency in Women: Beyond Pregnancy and Menorrhagia

02:40 – 03:00
Thrombosis and Pregnancy: Risk Stratification and Anticoagulation Strategies

Prof. Farjah AlQahtani 🇸🇦

Thrombosis and Pregnancy: Risk Stratification and Anticoagulation Strategies

03:00 – 03:20
Approach to Thrombocytopenia in Pregnancy: Distinguishing ITP, Gestational, and Pre-eclampsia-Related Causes

Prof. Sarah Sewaralthahab 🇸🇦

Approach to Thrombocytopenia in Pregnancy: Distinguishing ITP, Gestational, and Pre-eclampsia-Related Causes

03:20 – 03:40
Inherited Thrombophilias in Women: To Screen or Not to Screen?

Moozah AlMarshodi

Inherited Thrombophilias in Women: To Screen or Not to Screen?

03:40 – 03:50

Q&A

03:50 – 04:00

Break

04:00 – 04:20
Protein C deficiency: Review, Research & Updates

Dr. Faisal Alghamdi

Protein C deficiency: Review, Research & Updates

4:00 to 5:30
Protein C deficiency: Review, Research & Updates

Dr. Faisal AlGhamdi 🇸🇦

Protein C deficiency: Review, Research & Updates

8:00 – 9:00

Satellite Symposium

9:00 – 9:20
Novel approaches & Targeted therapy in AML

Dr. Richard Dillon 🇬🇧

Novel approaches & Targeted therapy in AML

9:20 – 9:40
Ph+ ALL non-chemotherapy approaches, is the time right?

Eman AboDallah

Ph+ ALL non-chemotherapy approaches, is the time right?

9:40 – 10:00
Therapeutic approaches in treating R/R AML: How I treat secondary acute myeloid leukemia

Dr. Mansour AlFayez 🇸🇦

Therapeutic approaches in treating R/R AML: How I treat secondary acute myeloid leukemia

10:00 – 10:20
Post-transplant maintenance for who, when and how long

Dr. Richard Dillon 🇬🇧

Post-transplant maintenance for who, when and how long

10:20 – 10:30

Q&A

10:30 – 11:00

Break

11:00 – 11:20
Clonal Evolution in MDS: From Initiating Mutations to Disease Progression

Dr. Syed Osman 🇸🇦

Clonal Evolution in MDS: From Initiating Mutations to Disease Progression

11:20 – 11:40
Personalized Risk Stratification in MDS: Beyond IPSS-R

Dr. Valeria Santini 🇮🇹

Personalized Risk Stratification in MDS: Beyond IPSS-R

11:40 – 12:00
Anemia Management in Lower-Risk MDS: Erythropoiesis-Stimulating Agents and Emerging Therapies

Dr. Fatimah AlShalati 🇸🇦

Anemia Management in Lower-Risk MDS: Erythropoiesis-Stimulating Agents and Emerging Therapies

12:00 – 12:20
Allogeneic Stem Cell Transplantation in MDS: Who, When, and How?

Dr. Valeria Santini 🇮🇹

Allogeneic Stem Cell Transplantation in MDS: Who, When, and How?

12:20 – 12:30

Q&A

12:30 – 13:30

Lunch

13:30 – 14:20

Satellite Symposium

14:00 – 14:20
CART vs Bispecifics in Lymphoma: How to Stratigize

Dr. Abdelwahab AlBabtain 🇸🇦

CART vs Bispecifics in Lymphoma: How to Stratigize

14:20 – 14: 40
Management of Relapsed or Refractory Aggressive Lymphomas: Salvage Therapy and New Treatment Options

Prof. Andrew Davies 🇬🇧

Management of Relapsed or Refractory Aggressive Lymphomas: Salvage Therapy and New Treatment Options

14:40 – 15:00
CNS Involvement in Aggressive Lymphomas: Detection and Management

Dr. Khalil Al-Farsi 🇴🇲

CNS Involvement in Aggressive Lymphomas: Detection and Management

15:00 – 15:20
1st line therapy in HL: Evolving Standards with Brentuximab and Checkpoint Inhibitors

Dr. Alfadel Alshaibani 🇸🇦

1st line therapy in HL: Evolving Standards with Brentuximab and Checkpoint Inhibitors

15:20 – 15:30

Q&A

03:50 – 04:00

Break

08:00 – 08:30

Integrative Nursing Roles in Hematology: From Acute Care to Survivorship

08:30 – 09:00

Nursing-Led Innovations in Managing Hematologic Toxicities

09:00 – 09:30

Hematology Nurse Navigation: Optimizing the Patient Journey

09:30 – 10:00

Hematology Nursing in the Era of Cell and Gene Therapy

10:00 – 10:30

Palliative Care Integration in Hematology: The Nurse’s Role

10:30 – 10:40

Q&A

10:40 – 11:00

Break

11:00 – 11:30

Redesigning Patient-Centered Hematology Care: The Role of Advanced Practice Nurses in Integrative Models

11:30 – 12:00

Value-Based Hematology Nursing: Enhancing Outcomes While Reducing Burden

12:00 – 12:30

Patient Blood Management (PBM) and Transfusion Safety: Nursing-Led Strategies

12:30 – 13:30

Lunch

13:30 – 14:20

Satellite Symposium

Session 3: Dental

Session 3: Dental

02:20 – 03:40
Dr. Hani Fadel

Dr. Hani T Fadel 🇸🇦

Dr. Hani Fadel

03:40 – 03:50

Q&A

03:50 – 04:00

Break

Session 4: Dental

04:00 – 05:30
Session 4: Dental

Dr. Hani T Fadel 🇸🇦

Session 4: Dental

8:30 – 09:00
Horizons of Prophetic Guidance: A Health Perspective

prof. Dr. Hassan Chamsi 🇸🇦

Horizons of Prophetic Guidance: A Health Perspective

9:00 – 9:30
The role of Cupping Therapy in Thalassemia disorder for precision medicine

Salah AlSayed 🇸🇦

The role of Cupping Therapy in Thalassemia disorder for precision medicine

9:30 – 10:00
Prophetic And Precision Medicine in the Spotlight: Global Research Trends And Scientific Breakthroughs

Soaad AlJaaony 🇸🇦

Prophetic And Precision Medicine in the Spotlight: Global Research Trends And Scientific Breakthroughs

10:00 – 10:30
AlMadinah History and Landmarkes

Abdullah Kaber

AlMadinah History and Landmarkes

10:30 – 11:00

Q&A

11:00 – 14:00

Friday Prayer & Lunch

14:00 – 14:20
Updates in ITP

Dr. Hanny Al-Samkari 🇺🇸

Updates in ITP

14:20 – 14: 40
TTP In the Era of new therapies

Dr. Mansoor Radwi 🇸🇦

TTP In the Era of new therapies

14:40 – 15:00
Management of TCP in special populations: Caner, liver disease, ICU

Dr. Hanny Al-Samkari 🇺🇸

Management of TCP in special populations: Caner, liver disease, ICU

15:00 – 15:20
Anti-PF4 disorders

Hazza Alzahrani

Anti-PF4 disorders

15:20 – 15:30

Q&A

15:30 – 15:50

Break

15:50 – 16:10
Perioperative Anticoagulation Management: Bridging or Holding?

Dr. Murad Almowarey 🇸🇦

Perioperative Anticoagulation Management: Bridging or Holding?

16:10 – 16:30
Approach to Thrombocytopenia Before Surgery: When to Delay, Transfuse, or Proceed

Prof. Mehran Karimi 🇮🇷

Approach to Thrombocytopenia Before Surgery: When to Delay, Transfuse, or Proceed

16:30 – 16:50
Consultative Hematology in Unexpected Bleeding: When Routine Coagulation Tests Are Normal

Dr. Azzah alzahrani 🇸🇦

Consultative Hematology in Unexpected Bleeding: When Routine Coagulation Tests Are Normal

16:50 – 17:10

Optimization of Anemia Before Elective Surgery: Patient Blood Management Principles

17:10 – 17:20

Q&A

17:20 – 18:10

Satellite Symposium

08:30 – 08:50
Hemoglobinopathies: Dental Perspective

Dr. Hani T Fadel 🇸🇦

Hemoglobinopathies: Dental Perspective

08:50 – 09:10
Why Dental Clearance before Hematologic Treatment Matters

TIF

Why Dental Clearance before Hematologic Treatment Matters

09:10 – 09:30
Managing Dental Surgeries in Patients with Coagulopathies: What We Need from Hematologists

TIF

Managing Dental Surgeries in Patients with Coagulopathies: What We Need from Hematologists

09:30 – 09:50
Timing of Elective Dental Procedures Around Chemotherapy and HSCT

TIF

Timing of Elective Dental Procedures Around Chemotherapy and HSCT

09:50 – 10:00

Q&A

10:00 – 10:20
Hematology Health Economic

Dr. Anas Hamad 🇶🇦

Hematology Health Economic

10:20 – 10:40

? transplant ID

10:40 – 11:00
Acquired Bleeding Disorders in Malignancy

Prof. Murtadha Al-Kabori 🇴🇲

Acquired Bleeding Disorders in Malignancy

11:00 – 14:00

Friday Prayer & Lunch

14:00 – 14:20
Updates on low-grade NHL classification

Dr. Fatimah Alturkistani 🇸🇦

Updates on low-grade NHL classification

14:20 – 14: 40
Mantle Cell Lymphoma (MCL) treatment updates

Andrew Davies

Mantle Cell Lymphoma (MCL) treatment updates

14:40 – 15:00
Novel Therapies for Relapsed Follicular Lymphoma

Abdulwahhab Alturah

Novel Therapies for Relapsed Follicular Lymphoma

15:00 – 15:20
T Cell Lymphoma Treatment Updates

Prof. Mubarak Al-Mansour 🇸🇦

T Cell Lymphoma Treatment Updates

15:20 – 15:30

Q&A

15:30 – 15:50

Break

15:50 – 16:10
Quadruple Therapy in Transplant-Eligible NDMM

Dr. Faiz Anwar 🇺🇸

Quadruple Therapy in Transplant-Eligible NDMM

16:10 – 16:30
Quad-Based Regimens in Transplant-Ineligible NDMM: Balancing Efficacy and Tolerability

Dr. Omar Abduljalil 🇸🇦

Quad-Based Regimens in Transplant-Ineligible NDMM: Balancing Efficacy and Tolerability

16:30 – 16:50
To Double or Not to Double: The Case for Anti-CD38 in Myeloma Mantenance (Mod: Ayman Alhejazi)

Faiz Anwar & Badraa AlMuhareb

To Double or Not to Double: The Case for Anti-CD38 in Myeloma Mantenance (Mod: Ayman Alhejazi)

16:50 – 17:10
Bisepcific Antibodies: A New Era in Myeloma Therapy

Ghazi AlOtaibi 🇸🇦

Bisepcific Antibodies: A New Era in Myeloma Therapy

17:10 – 17:20

Q&A

17:20 – 18:10

Satellite Symposium

Session 1: Psychosocial Support in SCD/Thal

8:30:00 AM
تعارف ابداعي خلاق

Dr. Ahmed Hafiz 🇸🇦

تعارف ابداعي خلاق

9:00:00 AM
تطبيق مقياس نفسي مسحي سريع للسادة الحضور

Nawarah Khaled

تطبيق مقياس نفسي مسحي سريع للسادة الحضور

9:30:00 AM
تطبيق الاسترخاء

Dr. Kawsar Sayed Alem 🇦🇫

تطبيق الاسترخاء

10:00:00 AM
شرح تقنيات الاسترخاء و فوائده

Tahani Dawood

شرح تقنيات الاسترخاء و فوائده

10:30:00 AM
 أهمية العلاج السلوكي المعرفي

Ms. Anhar Ali 🇸🇦

أهمية العلاج السلوكي المعرفي

11:00:00 AM

الملخص

11:00 – 14:00:

Friday Prayer & Lunch

Session 2: Patient SCD Program

14:00 – 14:20

TBD

Understanding Sickle Cell Disease: What’s Happening in the Body?

14:20 – 14: 40

TBD

Medications in Sickle Cell: What They Do and Why You Need Them

14:40 – 15:00

TBD

Coping with Chronic Pain and Fatigue

15:00 – 15:20

TBD

Nutrition and Lifestyle Tips for Living Better with SCD // How to advance care by joining trials

15:20 – 15:30

Q&A

15:30 – 15:50

Break

8:30 – 9:30

Satellite Symposium

Session 3: Patient SCD Program

02:20 – 02:40

TBD

Staying Active Safely: Exercise, Physical Therapy, and Movement

02:40 – 03:00

TBD

Travel and Daily Life with Sickle Cell: How to Prepare and Protect Yourself

03:00 – 03:20

TBD

Mental Health and Sickle Cell: You Are Not Alone

03:20 – 03:40

TBD

Caring for Children with Sickle Cell: A Guide for Parents and Families

03:40 – 03:50

Q&A

17:20 – 18:10

Satellite Symposium

8:00 – 9:00

Satellite Symposium

9:00 – 9:20
Modern Approaches to Managing Acute Vaso-Occlusive Crises

Dr. Saif Elislam 🇸🇦

Modern Approaches to Managing Acute Vaso-Occlusive Crises

9:20 – 9:40
Chronic Complications of Sickle Cell Disease: Kidney, Heart, and Lung Involvement

Salam AlKindi 🇴🇲

Chronic Complications of Sickle Cell Disease: Kidney, Heart, and Lung Involvement

9:40 – 10:00
Novel Therapies in Sickle cell disease

Abdullah Alzayed

Novel Therapies in Sickle cell disease

10:00 – 10:20
Rare but Real: Uncommon Complications in Sickle Cell Disease and Their Management

Dr. Hafiz Malhan 🇸🇦

Rare but Real: Uncommon Complications in Sickle Cell Disease and Their Management

10:20 – 10:30

Q&A

10:30 – 11:00

Break

11:00 – 11:20
Chronic Iron Overload: Monitoring and Managing Complications

Prof. Amal El-Beshlawy 🇪🇬

Chronic Iron Overload: Monitoring and Managing Complications

11:20 – 11:40
Multidisciplinary Clinics for Thalassemia: Building the Ideal Care Model

Dr. Marwa Zakaria 🇪🇬

Multidisciplinary Clinics for Thalassemia: Building the Ideal Care Model

11:40 – 12:00
New Horizons in Medical Management of Thalassemia: Beyond Transfusion and Chelation

Ali Taher

New Horizons in Medical Management of Thalassemia: Beyond Transfusion and Chelation

12:00 – 12:20
Pregnancy in Women with Thalassemia: Risk Assessment and Care Planning

Mona Hamdy 🇪🇬

Pregnancy in Women with Thalassemia: Risk Assessment and Care Planning

12:20 – 12:30

Q&A

12:30 – 13:30

Lunch

13:30 – 14:00

Satellite Symposium

14:00 – 14:20
Hematopoietic Stem Cell Transplantation in Benign Hematologic Disorders

Dr. Mattia Algeri 🇮🇹

Hematopoietic Stem Cell Transplantation in Benign Hematologic Disorders

14:20 – 14:40
Gene Editing and Gene Therapy for Benign Hematologic Diseases: What’s on the Horizon?

Dr.Erfan Nur 🇵🇱

Gene Editing and Gene Therapy for Benign Hematologic Diseases: What’s on the Horizon?

14:40 – 15:00
Patients selection and ethical considerations

Mohsen AlZahrani

Patients selection and ethical considerations

15:00 – 15:15
Gene Therapy in SCD:  Saudi Experience

Mohammed AlEissa

Gene Therapy in SCD: Saudi Experience

15:15 – 15:30
Gene Therapy in Benign Hematology: Italian Experience

Mattia Algeri

Gene Therapy in Benign Hematology: Italian Experience

15:30 – 15:45
Gene Therapy in Benign Hematology: Netherland Experience

Dr.Erfan Nur 🇵🇱

Gene Therapy in Benign Hematology: Netherland Experience

15:45 – 16:00
Gene Therapy in Hemophilia:  Saudi Experience

Dr. Shaikhah Alotaibi 🇸🇦

Gene Therapy in Hemophilia: Saudi Experience

16:00 – 16:15

Q&A

8:00 – 9:00

Satellite Symposium

Session 1: HSCT & Cellular Therapy

9:00 – 9:20
Is CAR-T in B-ALL a bridging or definitive therapy?

Dr. Ayman Saad 🇸🇦

Is CAR-T in B-ALL a bridging or definitive therapy?

9:20 – 9:40
7 years of CAR-T in Lymphoma, is it curative?

Dr. Riad El Fakih 🇺🇸

7 years of CAR-T in Lymphoma, is it curative?

9:40 – 10:00
GVHD What's new?

Dr. Sharukh Hashmi 🇦🇪

GVHD What's new?

10:00 – 10:20
Next generation CAR-Ts.. where do we stand?

Syed Farhayullah

Next generation CAR-Ts.. where do we stand?

10:20 – 10:30

Q&A

10:30 – 11:00

Break

Session 2: Peds Leukemias

14:20 – 14:40
Targeted Therapy in B-ALL: Timing CAR-T and Inotuzumab for Maximum Impac

Dr. Sarah Tasian 🇺🇸

Targeted Therapy in B-ALL: Timing CAR-T and Inotuzumab for Maximum Impac

14:40 – 15:00
Harmonizing approach for Pediatric AML management in KSA  , Focus on protocol choice and MRD assessment

Dr. Wasil Jastaniah 🇸🇦

Harmonizing approach for Pediatric AML management in KSA , Focus on protocol choice and MRD assessment

15:00 – 15:20
Upfront therapy in Pediatric Hodgkin Lymphoma

Sami Al thubaiti 🇸🇦

Upfront therapy in Pediatric Hodgkin Lymphoma

15:20 – 15:40
Incorporating Blinatumomab in upfront  management of pediatric B-ALL

Rayan alzighaiby

Incorporating Blinatumomab in upfront management of pediatric B-ALL

15:40 – 15:50

Q&A

12:30 – 13:30

Lunch

13:30 – 14:20

Satellite Symposium

14:00

Session 3: MPNs

02:20 – 02:40
Updates in Diagnosis and Management of  MPNs

Dr. Naeem Arshad 🇸🇦

Updates in Diagnosis and Management of MPNs

02:40 – 03:00
Understanding Triple Negative MPNs

Dr. Ayel Yahya 🇸🇦

Understanding Triple Negative MPNs

03:00 – 03:20
Advances in Targeted and JAK2 Inhibition Therapy in MPNs

Dr. Mohammed Yassin 🇶🇦

Advances in Targeted and JAK2 Inhibition Therapy in MPNs

03:20 – 03:40
Symptom Management in Myeloproliferative Neoplasms: Focus on Quality of Life

Dr. Aamer Aleem 🇸🇦

Symptom Management in Myeloproliferative Neoplasms: Focus on Quality of Life

03:40 – 03:50

Q&A

8:30 – 9:30

Satellite Symposium

Session 1: Patient Thal Program

9:00 – 9:20

What is Thalassemia? Understanding your Condition

9:20 – 9:40

Living with Transfusions: What to Expect and How to Prepare

9:40 – 10:00

Iron Overload and Chelation Therapy: Why It Matters

10:00 – 10:20

How Thalassemia Affects the Body: Long-Term Complications & Screening

10:20 – 10:30

Q&A

10:30 – 11:00

Break

Session 2: Patient Thal Program

11:00 – 11:20

TBD

Nutrition for Thalassemia: What to Eat and What to Avoid

11:20 – 11:40

TBD

Mental Health and Chronic Illness: Support for Patients and Families

11:40 – 12:00

TBD

Raising a Child with Thalassemia: A Parent’s Guide

12:00 – 12:20

TBD

Travel, Work, and Living Fully with Thalassemia

12:20 – 12:30

Q&A

12:30 – 13:30

Lunch

13:30 – 14:20

Satellite Symposium

Session 3: Patients – Common Topics in SCD & Thal

14:20 – 14:40

TBD

Living Well with a Chronic Blood Disorder: Empowering Your Daily Life

14:40 – 15:00

TBD

New Frontiers: Gene Therapy and Emerging Treatments

15:00 – 15:20

TBD

Infection Prevention & Vaccines: Staying Protected

15:20 – 15:40

TBD

Patient Rights and Medical Decision-Making: What You Should Know

15:40 – 15:50

Q&A

Contact Us
1